Kuliah Farmasi Fisika II (Nanoteknologi)
Kuliah Farmasi Fisika II (Nanoteknologi)
Kuliah Farmasi Fisika II (Nanoteknologi)
Fea Prihapsara
Fullerenes C60
22 cm
12,756 Km
1.27 107
m
0.22
m
10 millions
times smaller
0.7 nm
www.physics.ucr.edu
ww.mathworks.com
What is Nanoscale
0.7 10-9
m
1 billion
times
smaller
6/21/16
Nanodiagnostics:
diagnostics
on the
Regenerative Medicine:
repair
stimulated
10
table 4.1
6/21/16
11
History of Nanotechnology
~ 2000 Years Ago
Sulfide nanocrystals used by Greeks and
Romans to dye hair
1974 Nanotechnology
- Taniguchi uses the term nanotechnology for the first time
discover C 60
12
History of Nanotechnology
1986 Engines of Creation
- First book on nanotechnology by K. Eric Drexler.
Atomic Force Microscope invented by Binnig, Quate
and Gerbe
1989 IBM logo made with individual atoms
1991 Carbon nanotube discovered by S. Iijima
1999 Nanomedicine 1st nanomedicine book
by R. Freitas
2000 National Nanotechnology Initiative launched
(USA)
6/21/16
13
Nanotechnology
Applications of nanotechnology:
6/21/16
14
Salamanca-Buentello, F., et al. (2005). Nanotechnology and the Developing World. PLoS Med, 2(5), 383-386.
15
6/21/16
16
Nanotechnology
Applications
Information Technology
Energy
Medicine
Cancer treatment
Bone treatment
Drug delivery
Appetite control
Drug development
Medical tools
Diagnostic tests
Imaging
6/21/16
Solar cells
Fuel cells
Batteries
Bio fuels
Consumer Goods
Foods and beverages
Advanced packaging materials,
sensors, and lab-on-chips for
food quality testing
Nanoscale Materials
Protein
Bionanomaterials
1)Biological materials utilized
in nanotechnology
- Proteins, enzymes, DNA, RNA, peptides
2) Synthetic nanomaterials
utilized in biomedical
applications
Cross-linked enzymes
used as catalyst Univ. of
Connecticut, Storrs , 2007
6/21/16silicon
Porous
Human cell on
Enzymes
are used
as
oxidation
catalysts
Medical Nanotechnology or
Nanomedicine
6/21/16
19
Nanomedicine
A vehicle for delivery of therapeutics into the body
Dube A, Ng K, Nicolazzo JA, Larson I. Effective use of reducing agents and nanoparticle encapsulation in stabilizing
catechins in alkaline solution. Food Chemistry. 2010;122(3):662-7.
5
Dube A, Nicolazzo JA, Larson I. Chitosan nanoparticles enhance the plasma exposure of ()-epigallocatechin gallate
in mice through an enhancement in intestinal stability. European Journal of Pharmaceutical Sciences.
2011;44(3):422-6.
6/21/16
21
6
Boyd, B. J. (2008). Past and future evolution in colloidal drug delivery systems. Expert Opinion on Drug Delivery, 5,
4
Nanoparticles8
6/21/16
8
Re F, Moresco R, Masserini M. Nanoparticles for neuroimaging. Journal of Physics D: Applied Physics. 2012;45(7):073001.
23
6/21/16
24
6/21/16
25
Nano-Techniques
26
Particle Characterization
6/21/16
27
In Vitro:
Physicochemical:
Pharmacology
Size and Shape
Blood contact
Composition
properties
Molecular
Immune cell
weight
function
Surface
Cytotoxicity
chemistry
Mechanistic
Identity
toxicology
Purity
Sterility
Stability
Solubility
6/21/16
In Vivo:
ADME
Safety
Efficacy
28
6/21/16
29
Homogenizati
on
Energy
Milling
Cryogenic
Approaches
Super-Critical Fluid
Technologies
Spray Freezing into
Liquid
Ultra-rapid Freezing
6/21/16
BottomUp
NANOPARTICLES
Precipitation
EmulsionGrowt Diffusion
SOLUTION
31
Drug Delivery
A. Because of their small sizes, nanoparticles
are taken by cells where large particles would
be excluded or cleared from the body
1) A
nanoparticle
carries
the
pharmaceutical agent inside its
core,
while
its
shell
is
functionalized with a binding
agent
3) The
nanoparticle
is
ingested
inside the cell, and interacts with
the biomolecules inside the cell
6/21/16
Source: Comprehensive Cancer Center Ohio
University
A Drug Delivery
A. Nanoparticle
Nanoparticles for drug delivery can be metal-, polymer-, or
lipid-based.
B. Below (left) an example of the latter, containing SiRNA
encapsulated, and functionalized with an specific antibody.
SiRNA can control often lethal inflammatory body responses,
as shown in the microscopic images below (right)
B.
C.
lipid
antibo
dy
SiRNA
Healthy tissue
34
6/21/16
35
Modulation of PK profiles of TB
drugs12
6/21/16
36
Sharma,
A., R. Pandey, et al. (2004). "Chemotherapeutic efficacy of poly (DL-lactide-co-glycolide) nanoparticle
encapsulated antitubercular drugs at sub-therapeutic dose against experimental tuberculosis." Int J Antimicrob
12
TB drugs present
at MIC levels at
Day 7 and Day 9.
In the case of free
drugs, no drug
could be detected
in these tissues
after 48 h
6/21/16
37
Sharma,
A., R. Pandey, et al. (2004). "Chemotherapeutic efficacy of poly (DL-lactide-co-glycolide) nanoparticle
encapsulated antitubercular drugs at sub-therapeutic dose against experimental tuberculosis." Int J Antimicrob
12
6/21/16
38
39
6/21/16
40
-1
(1 m)
Hair (80 m)
6/21/16
-2
-3
-4
-5
(1 mm)
RBC (7 m)
Dermal risk
issues
Exposure
Absorption
Intrinsic Toxicity
10-6 m
(1 m)
10-7
Apparent
cut off
MW=500
nm
m 0.9 10
m
-8
(100 nm)
(10 nm)
Penetrate
skin
10-9 m
(1 nm)
10-10 m
(0.1 nm)
50nm
Rhinovirus
(25 nm)
ZnO
nanoparticles
6/21/16
42
Application
Title
Key
Language/Abstra
ct (relevant
claim in bold
Date of
Filed
Published
Applicati
on/
Patent
Number
ColgatePalmolive
Deodorant
with small
particle zinc
oxide
This invention
comprises a one
phase cosmetic
composition
which can be
made as a stick,
gel or cream
February 9,
2001
6358499
LOreal
Cosmetic
composition
comprising a
polyglycerol
ated silicone
elastomer
Nanoparticles
are between 5
nm and 600 nm
in size
March 22,
2005
2005220728
6/21/16
43
6/21/16
44
NANOEMULSION
Nanoemulsion (NE) are submicron sized, the
6/21/16
45
Application
NE in cosmetics
NE in mucosal vaccines system.
Antimicrobial NE.
NE in non-toxic disinfectant cleaner.
NE in cancer therapy & in targeted
drug delivery.
NE in various disease condition.
NE formulations for improve oral
delivery of poorly soluble drugs.
NE as a vehicle for TDDS.
Solid SNEDDS as a platform tech. for
formulation of poorly soluble drugs
6/21/16
46
47
Self-nanoemulsifying drug
delivery systems (SNEDDS)
The self-nano-emulsifying drug
delivery system (SNEDDS) is for
non-invasive delivery of protein
drugs.
E.g., Fluorescent-labeled betalactamase, a model protein, was
loaded into SNEDDS through the
solid dispersion technique.
6/21/16
48
SEDDS
droplet size
between 100 and
300 nm
Oil phase 40-50%
SNEDDS
49
ADVANTAGES OF SNEDDS:
Improvement in oral bioavailability:
SNEDDS to present the drug to GIT in solubilised and
micro emulsified form (globule size between 1-100 nm)
and subsequent increase in specific surface area
E.g. In case of halofantrine approximately 6-8 fold
increase in BA of drug was reported in comparison
to tablet formulation.
Ease of manufacture and scale-up:
Ease of manufacture and scale up is one of the most
important advantage that makes SNEDDS unique when
compared to other drug delivery systems like solid
dispersions, liposomes, nanoparticles, etc., dealing with
improvement of BA.
Reduction in inter-subject and intra-subject
variability and food effects:
Several research papers specifying that, the
performance of SNEDDS is independent of food 50
6/21/16
and, SNEDDS offer reproducibility of plasma profile are
51
Since the particle size is small, the total surface area for
absorption and dispersion is significantly larger than that of solid
dosage form and it can easily penetrate the gastrointestinal tract
and be absorbed The bioavailability of the drug is therefore
improved.
52
Dry emulsion
A novel oral dosage formulation of insulin consisting
of a surfactant, a vegetable oil, and a pH-responsive
polymer has been developed. First, a solid-in-oil (S/O)
suspension containing a surfactantinsulin complex
was prepared.
Solid-in-oil-in-water (S/O/W) emulsions were obtained
by homogenizing the S/O suspension and the aqueous
solution of hydroxypropylmethylcellulose phthalate
(HPMCP).
6/21/16
54
Tamoxifen Citrate
VAN Life Sciences Pvt Ltd, www.van.in
Formulation
Cmax (ng/ml)
Tmax (h)
AUC0-(ng/ml-h)
t1/2 (h)
TMX-SNEDDS
680.1255.54
2.0
9873.031
6.58
TMX citrate
solution
Commercial
formulation
275.5425.34
2.0
2628.71
4.77
TMX base
75.3312.34
4.0
1100.31
11.59
1
4-fold bioavailability enhancement compared to TMXcitrate and 9-fold enhancement compared to TMX free base
(TMX Dose : 10 mg/kg)
Formulation is physically and chemically stable at room
temperature for at least 6 months; Formulation is stable in
6/21/16
56
simulated
GI fluids for 8 hr.
6/21/16
57
Control
TmxCitrate
TmxSNEDDS
Parenchyma
l
degeneratio
n,
lymphocyte
infiltration,
and cell
apoptosis
Reddwall Solutions
Food
& Systems
Nutrition
Delivering
& Support
Nano-Tea
* Prepared with nano-technology,
the nano-tea can release effectively
all the excellent essences of the tea
thus, boosting the adsorption
(adsorbing viruses, free radicals,
cholesterol and blood fat) and
annihilation of viruses through
penetration so that a good
supplement of selenium can be
achieved and the selenium
supplement function can be
increased by 10 times.
59
Reddwall Solutions
Food
&
Delivering Systems & Support
Nutrition
Vitamin Supplement
* All Spray For Life products are
dispensed by the newly-designed
pre-metered, non-aerosol
Nanoceutical Delivery System (NDS)
administered transmucosally,
resulting in higher circulatory and
tissue levels (increasedbioavailability).
Water
Activated
60
Razor Blades
The FX Diamond razor uses
nanotechnology to create a
coating on its blades to make
them more durable.
Adding nano-particles to the
blade metal increases the
density, and thus the
hardness.
The Panasonic Arc electronic
razor uses nano-particles in its
6/21/16
blades
to increase their
61
Cancer Drugs
62
Cancer Drugs
63
ESTRASORB
*Immunosuppressant indicated
for the prophylaxis of organ
rejection in patients aged 13
years or older receiving renal
transplants.
6/21/16
(Launched,
December 2004)
*Cholesterol-lowering
drug that employs Elans
NanoCrystal Technology
to make it more easily
administrable.
MEGACE ES
Reproduction
Liquid Condom
Conclusion
For decades pharmaceutical sciences have been
using nanoparticles to reduce toxicity and side
effects of drugs;
Nanomedicine offers new prospects for many
drugs to be more effective and safe.
Nanotechnology changes the way we currently
view and understand drug delivery systems to
deliver drug to target site.
Further study is required including collaborative
efforts of Pharmacutical Industries and other
researchers from various institutions to deliver
nanosize drug delivery systems to the market.
6/21/16
67
6/21/16
70